1887
Preview this article:
Zoom in
Zoomout

compounds cross-reactive with galactomannan are detectable in culture supernatant but not in serum, Page 1 of 1

| /docserver/preview/fulltext/jmm/56/6/869-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47022-0
2007-06-01
2020-08-08
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/6/869.html?itemId=/content/journal/jmm/10.1099/jmm.0.47022-0&mimeType=html&fmt=ahah

References

  1. Ahmed A. O., van Leeuwen W., Fahal A., van de Sande W., Verbrugh H., van Belkum A. 2004; Mycetoma caused by Madurella mycetomatis : a neglected infectious burden. Lancet Infect Dis 4:566–574 [CrossRef]
    [Google Scholar]
  2. Becker M. J., Lugtenburg E. J., Cornelissen J. J., Van Der Schee C., Hoogsteden H. C., De Marie S. 2003; Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121:448–457 [CrossRef]
    [Google Scholar]
  3. Dalle F., Charles P. E., Blanc K., Caillot D., Chavanet P., Dromer F., Bonnin A. 2005; Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 43:2929–2931 [CrossRef]
    [Google Scholar]
  4. Marr K. A., Laverdiere M., Gugel A., Leisenring W. 2005; Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40:1762–1769 [CrossRef]
    [Google Scholar]
  5. Mennink-Kersten M. A., Donnelly J. P., Verweij P. E. 2004; Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4:349–357 [CrossRef]
    [Google Scholar]
  6. Park Y. I., Buszko M. L., Gander J. E. 1997; Utilization of phosphocholine from extracellular complex polysaccharide as a source of cytoplasmic choline derivatives in Penicillium fellutanum . J Bacteriol 179:1186–1192
    [Google Scholar]
  7. Swanink C. M., Meis J. F., Rijs A. J., Donnelly J. P., Verweij P. E. 1997; Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35:257–260
    [Google Scholar]
  8. van de Sande W. W., Luijendijk A., Ahmed A. O., Bakker-Woudenberg I. A., van Belkum A. 2005; Testing of the in vitro susceptibilities of Madurella mycetomati s to six antifungal agents by using the sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother 49:1364–1368 [CrossRef]
    [Google Scholar]
  9. Verweij P. E., Weemaes C. M., Curfs J. H., Bretagne S., Meis J. F. 2000; Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38:3900–3901
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47022-0
Loading
/content/journal/jmm/10.1099/jmm.0.47022-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error